ClinicalTrials.Veeva

Menu

Buzzy® Application in Pain

O

Okan University

Status

Completed

Conditions

Healthy

Treatments

Device: Buzzy

Study type

Interventional

Funder types

Other

Identifiers

NCT04990648
2018-17-02

Details and patient eligibility

About

The research was conducted as a randomized controlled experiment to investigate the effect of Buzzy® on pain level during the measles-rubella-mumps (MMR) vaccine injection in 12-month-old infants. This study was done with infants meeting the sampling criteria (buzzy group: 30, control group: 30) on November 2018-May 2019 in Istanbul Bakirkoy 9 Family Health Center.

Full description

To determine the effect of Buzzy® application on pain, which is a combination of cold and vibration, during measles-rubella-mumps (MMR) vaccine injection administration on 12-month-old infants. The study is a randomized contrlled experimental research. The research sample is composed of 60 infants (buzzy:30, control:30) who are 12-month-old injected MMR vaccine at Bakırköy No. 9 Family Health Center between November 2018-May 2019. As a data collection tool Data Collection Form, FLACC Pain Scale and Buzzy® device have been used. While Buzzy® was applied on infants in the trial group before, during and after the vaccine injection, the infants in the control group were applied routine vaccine injection. The pain response of the infants was evaluated by the nurse and the parent before, during and after the vaccine injection and the physiological parameters were evaluated by the nurse before and after the vaccine injection.

Enrollment

60 patients

Sex

All

Ages

12 to 12 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The baby has completed 12 months,
  • MMR vaccine will be applied,
  • Being at a suitable weight for the month,
  • The baby has not been given analgesic medication during the day,
  • It can be listed as the parent's willingness to participate in the research.

Exclusion criteria

  • It can be listed as having a body temperature above 37.5.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Buzzy group
Experimental group
Description:
Buzzy ® was placed on the left arm deltoid muscle site and kept there for 30 seconds. After 30 seconds, Buzzy ® was taken 1 cm up and MMR vaccine injection was administered to the left deltoid muscle site. After the vaccine injection, Buzzy ® was taken to the injection site and kept for another 30 seconds.
Treatment:
Device: Buzzy
Control group
No Intervention group
Description:
MMR vaccine injection was administered to the left deltoid muscle without any intervention or application to the injection site.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems